BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

ALVO upcoming catalysts

Alvotech USA Inc.: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 1 readout(s) and 2 FDA event(s). Subscribe to ALVO (.ics).

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
2025-11-26Complete response lettercomplete responseAlvotech USA Inc. ALVOAVTO5CRL 2025-11-26: Alvotech USA Inc. BLA 761461 (AVTO5)
2025-11-24Complete response lettercomplete responseAlvotech USA Inc. ALVOAVT06CRL 2025-11-24: Alvotech USA Inc. BLA 761435 (AVT06)

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2025-11-25P3Alvotech Swiss AG ALVONCT06570772 Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and EntyvioUlcerative Colitisterminated301

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.